Relevant Disclosure attached

Fortis Healthcare reported strong Q4 and full-year FY26 results. Q4 FY26 consolidated revenue rose 17.8% YoY to INR 2,365 Cr, with operating EBITDA up 22.2% to INR 531 Cr and margins expanding to 22.5% from 21.7%. PAT jumped 44.2% to INR 271 Cr despite a INR 12.5 Cr exceptional loss. For FY26, consolidated revenue grew 17.3% to INR 9,128 Cr, operating EBITDA surged 31.3% to INR 2,085 Cr with margins at 22.8% vs 20.4% in FY25, and PAT grew 31.5% to INR 1,064 Cr. Hospital business (85% of revenues) grew 19.1% to INR 7,773 Cr with margins at 22.2% vs 20.5%, driven by 15% increase in occupied beds. Diagnostics (Agilus) grew 8.5% to INR 1,527 Cr with margins at 23.6% vs 17.7%. Net debt stood at INR 2,334 Cr (Net Debt/EBITDA 1.09x), with the increase attributable to acquisitions including People Tree Hospital (Bengaluru) and Shrimann Hospital (Jalandhar). The board recommended a dividend of INR 1 per share. The company added ~500 beds via acquisitions in FY26 and plans a further ~1,800 bed capacity addition from FY27–FY30.